Your senior dog stares at the wall for minutes at a time. He wanders to the hinge side of the door and waits there, confused, as if he has forgotten how doors work. At 2 a.m. he paces, panting, through a house he has known for a decade. You tell yourself he is "just getting old," and in doing so you join the vast majority of owners: studies estimate that canine cognitive dysfunction syndrome (CDS) affects 28% of dogs aged 11–12 and up to 68% of dogs over 15, yet fewer than 2% are ever formally diagnosed. The gap between how common this disease is and how rarely it is recognized makes it one of the most under-treated conditions in veterinary medicine — and one of the most important for owners of aging dogs to understand.
What Canine Cognitive Dysfunction Actually Is
CDS is a progressive neurodegenerative disease of aging dogs that closely parallels Alzheimer's disease in humans. The brains of affected dogs show the same hallmark changes: deposits of beta-amyloid plaques around neurons, oxidative damage to brain cells, a decline in neurotransmitters — especially dopamine — and a gradual loss of neurons in areas responsible for memory, learning, and spatial awareness. Unlike the acute confusion of a urinary tract infection or the disorientation caused by sudden vision loss, CDS develops slowly over months to years. By the time an owner notices something is wrong, the disease has usually been progressing quietly for a long time.
The condition is sometimes called "dog dementia" or "doggy Alzheimer's," and while those labels are informal, they are not inaccurate. The biochemical overlap between CDS and human Alzheimer's is significant enough that dogs are now used as a natural model for studying the human disease, and some of the same therapeutic targets — antioxidants, neuroprotective agents, dietary interventions — are being investigated in both species.
The DISHAAL Warning Signs
Veterinary behaviorists use the acronym DISHAAL to organize the clinical signs of CDS into seven behavioral domains. Recognizing changes in even one or two of these categories in a senior dog is reason enough to bring it up with your vet:
- Disorientation — getting lost in familiar places, standing on the wrong side of the door, staring at walls or into corners, appearing confused in the yard or failing to find the food bowl.
- Interaction changes — reduced interest in greeting family members, less desire to be petted or held, withdrawal from social contact, or the opposite: new clinginess and following an owner from room to room.
- Sleep–wake cycle disturbances — pacing, panting, or vocalizing at night; sleeping much more during the day; a reversal of the normal schedule so the dog is restless when the household is trying to sleep.
- House soiling — urinating or defecating indoors despite years of reliable housetraining, with no underlying medical cause such as a urinary tract infection or gastrointestinal disease.
- Activity changes — aimless wandering or repetitive behaviors (circling, licking), decreased interest in play or toys, reduced exploratory behavior on walks.
- Anxiety — new fearfulness, increased vocalization (whining, barking at nothing), restlessness, agitation when left alone, or distress in response to changes that previously did not bother the dog.
- Learning and memory deficits — forgetting previously learned commands, failure to recognize familiar people or pets, inability to learn new routines or adapt to changes in the environment.
The most common early signs owners report are nighttime restlessness, staring into space, and getting "stuck" behind furniture or in corners. Because these changes creep in gradually, many owners attribute them to normal aging or dismiss them as quirks. The critical distinction is that normal aging slows a dog down; CDS changes who the dog is. A dog who has always slept through the night and now paces for hours is not simply aging — something has changed in the brain.
How Veterinarians Diagnose CDS
There is no single blood test, scan, or biomarker that confirms CDS in a living dog. It is a diagnosis of exclusion: the vet must first rule out every other condition that could produce the same behavioral changes. The workup typically includes a thorough physical and neurological exam, complete blood count, serum chemistry, urinalysis, thyroid panel, and blood pressure measurement. Depending on the signs, the vet may also recommend imaging (radiographs or MRI) to rule out brain tumors, and tests for pain, vision loss, or hearing loss — all of which can mimic CDS.
Once medical causes are excluded, the diagnosis relies on validated behavioral questionnaires filled out by the owner. The most widely used tools include the Canine Cognitive Dysfunction Rating scale (CCDR), the Canine Dementia Scale (CADES), and the DISHAAL questionnaire. These instruments score the frequency and severity of behavioral changes across the domains described above and help the vet distinguish mild cognitive impairment from moderate or severe disease. They also serve as a baseline against which future progression can be measured.
One of the biggest obstacles to diagnosis is that owners rarely volunteer cognitive complaints during wellness visits. A 2025 survey published in Frontiers in Veterinary Science found that despite an estimated prevalence of 14.2% in the general senior dog population, only 1.9% of cases were diagnosed. Veterinary organizations including the AAHA now recommend that cognitive screening be part of every senior and geriatric wellness exam, ideally starting around age seven for large breeds and age nine for smaller breeds.
Treatment: A Multimodal Approach
There is no cure for CDS, and the disease will progress over time. But early intervention with a combination of medication, diet, supplements, and environmental enrichment can slow the decline, reduce distressing symptoms, and meaningfully improve quality of life — for both the dog and the family. The current evidence strongly supports a multimodal strategy rather than relying on any single treatment.
Medication
Selegiline (marketed as Anipryl in the United States) is the only FDA-approved drug for CDS in dogs. It is a monoamine oxidase B (MAO-B) inhibitor that works by increasing dopamine levels in the brain — the same neurotransmitter that declines as CDS progresses. The standard dose is 0.5–1 mg/kg once daily in the morning. Owners should be aware that selegiline can take four to twelve weeks to show its full effect, so patience is important. Clinical studies have shown improvement in disorientation, sleep–wake disturbances, housetraining lapses, and social interactions in a significant proportion of treated dogs.
Selegiline should not be combined with certain other medications — particularly SSRIs, tricyclic antidepressants, or opioids — because of the risk of serotonin syndrome. Your vet will review your dog's full medication list before prescribing it. In some cases, veterinarians may also use other medications off-label to manage specific symptoms, such as trazodone or gabapentin for nighttime anxiety and restlessness.
Diet and Nutritional Support
Nutrition is one of the most promising frontiers in CDS management. A landmark double-blinded, placebo-controlled clinical trial published in Frontiers in Nutrition found that senior dogs fed a diet containing 6.5% medium-chain triglycerides (MCTs) showed significant improvement in all six DISHAA categories within 90 days, with measurable gains beginning as early as 30 days. MCTs provide the brain with ketone bodies — an alternative energy source when the brain's ability to metabolize glucose declines with age.
Several veterinary therapeutic diets are formulated specifically for cognitive support and combine MCTs with antioxidants (vitamins E and C, selenium, beta-carotene), B vitamins, omega-3 fatty acids (DHA and EPA), and other neuroprotective compounds. A 2025 systematic review analyzing 27 canine clinical trials concluded that complete, enriched therapeutic diets demonstrated stronger and more consistent cognitive benefits than single-ingredient supplements alone.
Supplements such as S-adenosylmethionine (SAMe), phosphatidylserine, and alpha-lipoic acid have shown promise in smaller studies and are commonly recommended as part of a comprehensive plan. However, they should complement — not replace — dietary and environmental interventions.
Environmental Enrichment and Daily Routine
Just as in human dementia care, environmental management plays a central role in supporting a dog with CDS. The brain benefits from consistent stimulation, and the dog benefits from a world that is predictable and easy to navigate. Practical steps include:
- Maintain a consistent daily routine — feed, walk, and settle the dog at the same times every day. Predictability reduces anxiety.
- Keep the environment simple — avoid rearranging furniture, and use nightlights in hallways to help a disoriented dog find their way at night.
- Provide gentle mental stimulation — food puzzles, sniff mats, short training sessions with familiar commands, and slow exploratory walks where the dog can sniff freely. The goal is engagement without frustration.
- Continue physical exercise — adjusted for the dog's ability. Even short, gentle walks support blood flow to the brain and help regulate the sleep–wake cycle.
- Manage nighttime restlessness — a comfortable, well-padded bed in a quiet area, a consistent bedtime routine, and daytime activity to promote nighttime sleep. White noise machines can help some dogs settle.
- Avoid punishment — a dog who house soils or seems confused is not being disobedient. Punishment increases anxiety and worsens symptoms. Patience, management (more frequent outdoor trips, waterproof pads), and compassion are the correct responses.
Living with CDS: Monitoring Progression and Quality of Life
CDS is progressive, and honest monitoring is essential. The same behavioral questionnaires used for diagnosis — CCDR, CADES, DISHAAL — can be repeated every three to six months to track changes over time. Some dogs plateau for months on treatment before declining further; others progress more steadily. Keeping a simple written log of your dog's daily behaviors — sleep quality, episodes of confusion, appetite, social engagement — gives your vet concrete data to work with and helps you spot subtle changes that might otherwise go unnoticed.
Quality of life is the guiding principle. A dog with mild CDS who is eating well, enjoying walks, and sleeping through most of the night with appropriate support can have many good months or even years ahead. When the bad days consistently outnumber the good ones — when anxiety is constant, nighttime distress cannot be managed, or the dog no longer recognizes the people they love — it is time for a compassionate conversation with your vet about what comes next. That conversation is never easy, but approaching it early and honestly is one of the most important things you can do for your dog.
What You Can Do Right Now
If your dog is over eight years old, start paying close attention to changes in sleep patterns, spatial awareness, social behavior, and housetraining reliability. Do not dismiss nighttime pacing, staring at walls, or getting stuck behind furniture as "just old age." Mention these changes at your next vet visit — or make an appointment specifically to discuss them. Ask about cognitive screening questionnaires, and discuss whether a therapeutic diet, selegiline, or a structured enrichment plan might benefit your dog. CDS cannot be cured, but catching it early gives you the best chance to slow it down and protect the quality of life your dog deserves in their final years.